Development of a strategy for a longitudinal study of patients with bladder cancer. National Bladder Cancer Collaborative Group A (NBCCGA).
出版信息
Cancer Res. 1977 Aug;37(8 Pt 2):2898-906.
PMID:326396
Abstract
摘要
相似文献
1
2
Cytology and histopathology of bladder cancer cases in a prospective longitudinal study. National Bladder Cancer Collaborative Group A.
Cancer Res. 1977 Aug;37(8 Pt 2):2911-5.
3
Bladder cancer.膀胱癌
Practitioner. 1982 Nov;226(1373):1891-8.
4
5
Endpoints of clinical trials for muscle-invasive bladder cancer.肌肉浸润性膀胱癌临床试验的终点
Prog Clin Biol Res. 1990;353:65-74.
6
Adjuvant chemotherapy of bladder cancer.膀胱癌的辅助化疗。
Prog Clin Biol Res. 1988;260:545-9.
7
Treatment of superficial bladder cancer.浅表性膀胱癌的治疗
Can Med Assoc J. 1980 May 24;122(10):1133-8.
8
Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
Prog Clin Biol Res. 1984;162B:397-427.
9
Management of bladder carcinoma.膀胱癌的管理
N Y State J Med. 1981 Jul;81(8):1201-6.
10
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.1998年至2003年III期膀胱癌围手术期化疗的低发生率：来自国家癌症数据库的报告。
J Urol. 2007 Aug;178(2):451-4. doi: 10.1016/j.juro.2007.03.101. Epub 2007 Jun 11.
引用本文的文献
1
Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.由国家膀胱癌项目资助的膀胱癌化疗研究。
Cancer Chemother Pharmacol. 1983;11 Suppl:S13-5.
Zotero 插件